info@salutesicilia.com

Breast cancer shift toward evil-ution: replacing growth factors with chemokines to thrive

Breast cancer shift toward evil-ution: replacing growth factors with chemokines to thrive

Medicomunicare Magazine

Breast cancer affects about 10% of women in their lifetime and is a serious medical and social burden. Fewer treatment options are available for breast cancers that lack estrogen receptors and therefore do not respond to hormone therapy. Breast tumors that lack not only ER-alpha, but also the EGFR tyrosine kinase receptor and the progesterone

Read More